Big pharmaceutical companies have signed an agreement to tackle the spread of superbugs as the UN prepares to discuss antimicrobial resistance.
Drugmakers including Johnson & Johnson, Pfizer and AstraZeneca said the world faced a “staggering threat” from drug-resistant superbugs and agreed to abide by a voluntary code of conduct designed to address the problem.
Antimicrobial resistance describes the phenomenon where antibiotics and other infection-fighting drugs no longer work effectively because bacteria have developed the ability to fight back.
您已阅读23%（550字），剩余77%（1812字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。